Sign In

Burton J. Tabaac, MD, FAHA

Vascular Neurologist, Associate Professor, Clinical Psychedelics Researcher

Dr. Burton J. Tabaac, MD, FAHA, is an accomplished Associate Professor of Neurology at The University of Nevada, Reno School of Medicine, specializing in advanced treatments for neurological disorders. He currently holds the positions of Section Chief of Neurology and Medical Director of Stroke at Carson Tahoe Health. Dr. Tabaac completed his fellowship in cerebrovascular neurology at The Johns Hopkins University Hospital, his MD at AUC School of Medicine, and his neurology residency at Rutgers Robert Wood Johnson, earning multiple awards for his excellence in teaching and humanism. He is a distinguished member of the Alpha Omega Alpha Honor Medical Society and a fellowship affiliate of the American Heart Association.

Highlights

Mar 23 · linkedin

I am very excited to share that The American Journal of Therapeutics has published our Special Issue on Psychedelic Therapy: A Primer for Primary Care Clinicians! These articles are aimed to educate physicians and clinicians on psychedelics as therapeutics.

The sections are as follows:

Historical Perspective and Overview Lysergic Acid Diethylamide (LSD) N,N-Dimethyltryptamine and Ayahuasca Psilocybin Ibogaine 3,4-Methylenedioxy-methamphetamine (MDMA) Ketamine The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics

There is also a Commentary authored by Lynn-Marie Morski MD, JD, the President of the Psychedelic Medicine Association.

The series abstracts and journal information can be found here: https://lnkd.in/gjC9h8ex

This comprehensive work was written by an accompaniment of coauthors from the following academic institutions: University of Oxford, University of Washington School of Medicine, University of Southern California, Keck School of Medicine, Stanford University, Icahn School of Medicine at Mount Sinai, Columbia University, Fermata Health, Acacia Clinics, and the University of Nevada, Reno School of Medicine

Psychedelic therapeutics aren’t taught in medical school. Help share knowledge!

Burton J. Tabaac, MD, FAHA
Add to my network

Location

United States